Angiogenesis in pituitary adenomas

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Microscopy research and technique (Print)

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jemt.10262PMID 12539178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas

  2004cited by this paper
• The fine structure of blood vessels in chromophobe adenoma

  2004cited by this paper
• Vascular Endothelial Growth Factor Production and Regulation in Rodent and Human Pituitary Tumor Cells in vitro

  2001influential reference
• Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

  2001cited by this paper
• Microvessel density in pituitary adenomas and carcinomas

  2001influential reference
• New Medical Approaches in Pituitary Adenomas

  2000cited by this paper
• Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.

  2000influential reference
• Proliferation, Vascular Endothelial Growth Factor Expression and Cavernous Sinus Invasion in Growth Hormone Secreting Pituitary Adenomas

  2000cited by this paper
• Angiogenesis in pituitary adenomas and the normal pituitary gland.

  2000influential reference
• Tumor angiogenesis: past, present and the near future.

  2000cited by this paper
• Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour

  2000influential reference
• Immunolocalization of vascular endothelial growth factor in the GH3 cell line

  2000cited by this paper
• Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells.

  2000cited by this paper
• Vascular endothelial growth factor in reproductive biology.

  1999cited by this paper
• Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours?

  1999cited by this paper
• Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells.

  1999cited by this paper
• Expression of von Hippel-Lindau Protein (VHL-P) in Nontumorous and Adenomatous Human Pituitaries

  1999cited by this paper
• Localization of vascular endothelial growth factor in nontumorous human pituitaries

  1999influential reference
• Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas

  1999cited by this paper
• Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis

  1999cited by this paper
• Age-dependent impairment of angiogenesis.

  1999cited by this paper
• Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis

  1998influential reference
• Placenta growth factor (PlGF) mRNA expression in brain tumors

  1998cited by this paper
• Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat.

  1998cited by this paper
• Tumor induction of VEGF promoter activity in stromal cells.

  1998cited by this paper
• Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).

  1997cited by this paper
• Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel density.

  1997cited by this paper
• Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study.

  1997cited by this paper
• Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.

  1997cited by this paper
• The biology of vascular endothelial growth factor.

  1997influential reference
• Immunocytochemical investigations on the vascularization of pituitary adenomas

  1997cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells(ヒトグリオーマ細胞における腫瘍壊死因子αによる血管内皮増殖因子の誘導)

  1997cited by this paper
• Biological roles of fibroblast growth factor-2.

  1997influential reference
• Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: expression is independent of hypothalamic control.

  1997influential reference
• Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review.

  1996influential reference
• Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.

  1996cited by this paper
• Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

  1996cited by this paper
• Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells

  1996cited by this paper
• Transcriptional regulation by hypoxia-inducible factor 1 molecular mechanisms of oxygen homeostasis.

  1996cited by this paper
• Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.

  1996cited by this paper
• Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.

  1995cited by this paper
• Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms

  1995influential reference
• Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study

  1995influential reference
• Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

  1995cited by this paper
• Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

  1995cited by this paper
• Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma.

  1994cited by this paper
• Localization of basic fibroblast growth factor (bFGFJ) protein and mRNA in human pituitaries: regulation of bFGF mRNA by gonadotropin-releasing hormone

  1994cited by this paper
• Immunohistochemical study for basic fibroblast growth factor and fibroblast growth factor receptor I in pituitary adenomas.

  1994cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Pituitary microadenomas: early enhancement with dynamic CT--implications of arterial blood supply and potential importance.

  1993cited by this paper
• Angiogenesis

  1993influential reference
• Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

  1992cited by this paper
• S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas

  1992cited by this paper
• Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas.

  1992cited by this paper
• Relation of neovascularisation to metastasis of non-small-cell lung cancer.

  1992cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

  1991cited by this paper
• Regulation of cutaneous wound healing by growth factors and the microenvironment.

  1991cited by this paper
• Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor

  1991cited by this paper
• Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats.

  1991cited by this paper
• Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells.

  1991cited by this paper
• Expression of basic fibroblast growth factor in normal human tissues.

  1990cited by this paper
• What is the evidence that tumors are angiogenesis dependent?

  1990cited by this paper
• Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.

  1989cited by this paper
• A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.

  1988cited by this paper
• Characteristics of the ACTH response to repeated pulses of corticotrophin-releasing factor and arginine vasopressin in vitro.

  1988cited by this paper
• Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly.

  1988cited by this paper
• Microadenomas of the human pituitary and their vascularization.

  1988cited by this paper
• Morphological evidence for the presence of arteries in human prolactinomas.

  1988cited by this paper
• Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats.

  1987cited by this paper
• Arterial supply of the human anterior pituitary gland.

  1987cited by this paper
• Microvasculature of human micro- and macroprolactinomas. A morphological study.

  1986influential reference
• A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion.

  1985cited by this paper
• Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.

  1982cited by this paper
• Angiogenesis as a marker of preneoplastic lesions of the human breast

  1978cited by this paper
• Vascular alterations in adenomas of human pituitary glands. An electron microscopic study.

  1973cited by this paper
• Ultrastructural changes in the capillary bed of human pituitary tumors.

  1972cited by this paper
• INTRATUMORAL VASCULAR CHANGES WITH INCREASED SIZE OF A MAMMARY ADENOCARCINOMA: NEW METHOD AND RESULTS.

  1965cited by this paper
• Vascular lesions in pituitary adenomas.

  1952cited by this paper
• Tumours

  1916cited by this paper

• First-in-human pilot study of snapshot multispectral endoscopy for delineation of pituitary adenoma

  2025cites this paper
• TFF3 promotes pituitary tumor cell migration and angiogenesis via VEGFA.

  2022cites this paper
• Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study.

  2020cites this paper
• Limited Utility of 5-ALA Optical Fluorescence in Endoscopic Endonasal Skull Base Surgery: A Multicenter Retrospective Study

  2020cites this paper
• Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors

  2019cites this paper
• Rigid Endoscopy for Intraoperative Imaging of Pituitary Adenoma

  2019cites this paper
• Trophic and neurotrophic factors in human pituitary adenomas (Review).

  2017cites this paper
• Selective molecular biomarkers to predict biologic behavior in pituitary tumors

  2017cites this paper
• Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas

  2016cites this paper
• Intraoperative Identification of a Normal Pituitary Gland and an Adenoma Using Near-Infrared Fluorescence Imaging and Low-Dose Indocyanine Green

  2016cites this paper
• Biomarkers of pituitary carcinomas

  2016influential citation
• Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach

  2015cites this paper
• Evaluation of the antiangiogenic effects of octreotide on growth hormone-producing pituitary adenoma using arterial spin-labeling perfusion imaging.

  2015cites this paper
• Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System

  2014cites this paper
• Endocan, a new invasion and angiogenesis marker of pituitary adenomas

  2014cites this paper
• "Leiomyomatoid angiomatous neuroendocrine tumor" (LANT) of the pituitary reflects idiosyncratic angiogenesis in adenomas of the gonadotroph cell lineage.

  2013cites this paper
• Microvascular morphometrics of the hypophysis and pituitary tumors: from bench to operating theatre.

  2013cites this paper
• Biomarkers of pituitary neoplasms.

  2012cites this paper
• Indocyanine green fluorescence endoscopy for visual differentiation of pituitary tumor from surrounding structures.

  2012cites this paper
• Radiological apoplexy and its correlation with acute clinical presentation, angiogenesis and tumor microvascular density in pituitary adenomas.

  2011cites this paper
• Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas

  2011cites this paper
• Biomarkers of Pituitary Neoplasms: A Review (Part II)

  2010influential citation
• New Insights into the Endocrine and Metabolic Roles of Dopamine D 2 Receptors Gained from the Drd 2 – / – Mouse

  2010cites this paper
• Effect of everolimus on cell viability in nonfunctioning pituitary adenomas.

  2010cites this paper
• The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells

  2010cites this paper
• New Insights into the Endocrine and Metabolic Roles of Dopamine D2 Receptors Gained from the Drd2–/– Mouse

  2010cites this paper
• Transcripts of PTTG and Growth Factors bFGF and IGF-1 are Correlated in Pituitary Adenomas

  2009cites this paper
• Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia

  2009influential citation
• Immunohistochemical expression of nestin in adenohypophysial vessels during development of pituitary infarction.

  2008cites this paper
• Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.

  2007cites this paper
• Study of the telomerase hTERT fraction, PCNA and CD34 expression on pituitary adenomas. Association with clinical and demographic characteristics

  2007cites this paper
• Oncogenesis and mutagenesis of pituitary tumors

  2006cites this paper
• Inhibition of Pro-Angiogenic Factors by a Lipid-Rich Shark Extract

  2006cites this paper
• Vascularization of rat pituitary autografts

  2006cites this paper
• Pituitary today : molecular, physiological and clinical aspects

  2006cites this paper
• Pattern of FGF-2 isoform expression correlated with its biological action in experimental prolactinomas

  2006cites this paper
• Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma.

  2006cites this paper
• Expression of hypoxia-inducible factor 1α and cathepsin D in pituitary adenomas

  2005cites this paper
• Expression of hypoxia-inducible factor 1alpha and cathepsin D in pituitary adenomas.

  2005cites this paper
• Markers of Vascular Function in Hypertension due to Cushing’s Syndrome

  2005cites this paper
• Markers of vascular function in hypertension due to Cushing's syndrome.

  2005cites this paper
• Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.

  2005cites this paper
• Prognostic indicators in pituitary tumors

  2005cites this paper
• Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in pituitary adenomas

  2005cites this paper
• Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis.

  2004cites this paper
• Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.

  2004cites this paper
• Vascular endothelial growth factor (VEGF), prostaglandin E2 (PGE2) and active renin in hypertension of adrenal origin

  2004cites this paper